Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Bioverge

Investor type Angel Group
Founders Neil Littman Rick Gibb

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 33
Average round size
info
The average size of a deal this fund participated in
$836K
Portfolio companies 28
Rounds per year 5.50
Lead investments 0
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.06
Exits 1
Key employees 1
Stages of investment
Early Stage Venture
Seed

Areas of investment

  • Biotechnology
  • Health Care
  • Therapeutics
  • Medical Device
  • Life Science
Summary

In 2016 was created Bioverge, which is appeared as Corporate Investor.

The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the Bioverge, startups are often financed by Venture University, VU Venture Partners, Thomas Glocer. The meaningful sponsors for the fund in investment in the same round are Thiel Capital, Techammer, Phil Libin.

We can highlight the next thriving fund investment areas, such as Artificial Intelligence, Therapeutics. Among the most popular portfolio startups of the fund, we may highlight OccamzRazor. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund.

The fund was created by Neil Littman, Rick Gibb.

The important activity for fund was in 2019. The fund is generally included in 2-6 deals every year. The usual things for fund are deals in the range of 1 - 5 millions dollars.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Bioverge:
Typical Co-investors
Bioverge is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Bioverge:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
2GIS Novosibirsk, Novosibirsk Oblast, Russia
Dijian Trading China, Guangdong, Tianjin
Essential Investment Partners -
French Public Bank of Investment -
G Street Capital China, Guangdong, Shenzhen
High Ground Capital Beijing, Beijing, China
Hunch Ventures Delhi, India, New Delhi
Iroquois Capital Nashville, Tennessee, United States
MAD Ventures GmbH Austria, Innsbruck, Tirol
Osmington Canada, Ontario, Toronto
Peak Opportunity Partners New York, New York, United States
Sand 9 Cambridge, Massachusetts, United States
Sandvine Canada, Ontario, Waterloo
Silver Lake California, Menlo Park, United States
SummitVision Capital, LLC California, San Francisco, United States
TD Veen Norway, Rogaland, Stavanger
The Japan Research Institute Japan, Setagaya
Tofino Capital District of Columbia, United States, Washington
Zhejiang Lusheng Shipen Keji Co., Ltd China, Ningbo, Zhejiang

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

NutriSense

Fitness
Health Care
Machine Learning
Wellness
$3M13 Sep 2021 Chicago, Illinois, United States

BioROSA Technologies

Biotechnology
Health Care
Life Science
Robotics
15 Jul 2021 Massachusetts, United States

Enveda Biosciences

Biotechnology
Pharmaceutical
Therapeutics
15 Jun 2021 San Francisco, California, United States

Juno Diagnostics

Biotechnology
Health Care
Health Diagnostics
25 May 2021 San Diego, California, United States

HepaTx

Biotechnology
Medical
Therapeutics
20 May 2021 Palo Alto, California, United States

Elucid

Analytics
Biotechnology
Medical Device
$10M10 May 2021 Boston, Massachusetts, United States

Elucid

Analytics
Biotechnology
Medical Device
17 Mar 2021 Boston, Massachusetts, United States

iviva medical

Construction
03 Mar 2021 Beverly, Massachusetts, United States

Ancilia Biosciences

Biotechnology
Health Care
Life Science
14 Dec 2020 -

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Bioverge?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: